Gerresheimer AG (ETR:GXI)‘s stock had its “buy” rating reissued by equities researchers at DZ Bank AG in a research note issued to investors on Monday, July 17th.
A number of other research firms also recently weighed in on GXI. Hauck & Aufhaeuser set a €80.00 ($94.12) price target on shares of Gerresheimer AG and gave the stock a “neutral” rating in a research note on Friday, July 14th. Deutsche Bank AG set a €82.00 ($96.47) target price on shares of Gerresheimer AG and gave the company a “buy” rating in a research note on Friday, July 14th. Goldman Sachs Group, Inc. (The) set a €73.00 ($85.88) target price on shares of Gerresheimer AG and gave the company a “neutral” rating in a research note on Friday, July 14th. Kepler Capital Markets set a €70.00 ($82.35) target price on shares of Gerresheimer AG and gave the company a “sell” rating in a research note on Thursday, July 13th. Finally, Commerzbank Ag set a €73.00 ($85.88) target price on shares of Gerresheimer AG and gave the company a “neutral” rating in a research note on Thursday, July 13th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and four have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of €79.80 ($93.88).
Shares of Gerresheimer AG (ETR:GXI) traded up 1.58% during mid-day trading on Monday, reaching €69.39. The company’s stock had a trading volume of 60 shares. The firm has a 50-day moving average of €70.07 and a 200-day moving average of €72.89. The firm has a market capitalization of €2.18 billion and a PE ratio of 19.22. Gerresheimer AG has a 52 week low of €64.00 and a 52 week high of €79.47.
COPYRIGHT VIOLATION NOTICE: “Gerresheimer AG (GXI) Rating Reiterated by DZ Bank AG” was first reported by Community Financial News and is owned by of Community Financial News. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The legal version of this story can be read at https://www.com-unik.info/2017/08/14/gerresheimer-ags-gxi-buy-rating-reiterated-at-dz-bank-ag-updated-updated-updated.html.
About Gerresheimer AG
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
What are top analysts saying about Gerresheimer AG? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Gerresheimer AG and related companies.